Ilaria Colombo

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Christina Guo, Adam Sharp, Bora Gürel et al. · Nature · 2023 · 103 citations · Full text

Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial

Nicoletta Colombo, Elena Biagioli, Kenichi Harano et al. · The Lancet Oncology · 2024 · 89 citations

Gynecological Surgery, Medicine, Metronomic Therapy +6

Acute and chronic aquatic toxicity of ammonium perfluorooctanoate (APFO) to freshwater organisms

Ilaria Colombo, Watze de Wolf, Roy S. Thompson et al. · Ecotoxicology and Environmental Safety · 2008 · 65 citations

Bioconcentration, Ammonium Perfluorooctanoate, Environmental Engineering +10

Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer

Stéphanie Lheureux, Daniela Matei, Panagiotis A. Konstantinopoulos et al. · Journal for ImmunoTherapy of Cancer · 2022 · 58 citations · Full text

An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)

Derek Clouthier, Scott Lien, S.Y. Cindy Yang et al. · Journal for ImmunoTherapy of Cancer · 2019 · 53 citations · Full text